News
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
The scalp microbiome comprises diverse bacteria, fungi, and yeast that interact with sebum, pH, and immune responses to ...
This commentary sets the article by Dubois on the ethical justification for charging higher insurance premiums for people with unhealthy lifestyles in the context of US health care reform. It ...
Uncomplicated skin infections account for almost 200 million physician-office visits in the USA annually. Treating these infections is estimated to cost in excess of US$350 million each year. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results